| 000 | 00781namaa22002054ar4500 | ||
|---|---|---|---|
| 001 | 021588 | ||
| 008 | 130822s2002 xxc f 1 eng d | ||
| 020 | _a1-894620-57-7 | ||
| 082 |
_a617.356 _bT258e _829 |
||
| 245 |
_aTechnology report : _bEfficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: systematic review and budget impact analysis / _cMichel Boucher ...[et al.] |
||
| 260 |
_aOttawa, Can. : _bCCOHTA, _c2002. |
||
| 300 | _a76 p. | ||
| 490 |
_aTechnology report ; _n29 |
||
| 650 |
_aDiabetes Mellitus _xDiagnóstico _xPrevención y Control. |
||
| 700 |
_aBoucher, Michel _ecoaut. |
||
| 700 |
_aBrown, Allan _ecoaut. |
||
| 700 |
_aMcAuley, Laure _ecoaut. |
||
| 710 | _aCanadian Coordination Office for Health Technology Assessment | ||
| 942 | _cBK | ||
| 999 |
_c9998 _d9998 |
||